Eritrea vs Mali: Cause of death, by non-communicable diseases, ages 5-14, male
Eritrea
20.2%
in 2021
Mali
21.3%
in 2021
Eritrea rank
147th
Mali rank
144th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Eritrea
- Mali
How they compare
Mali currently reports 21.3% against 20.2% in Eritrea, a difference of 1.1%.
That makes Mali's figure about 1.1 times Eritrea's.
Across all 6 years both countries report, Mali has been ahead every year.
Eritrea ranks 147th and Mali ranks 144th of 185 countries.
Mali has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.5% | 16.1% | 3.6% | Mali |
| 2010s | 17.4% | 20.4% | 2.9% | Mali |
| 2020s | 20.3% | 21.4% | 1.2% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Eritrea or Mali?
- Mali, at 21.3% against 20.2% in Eritrea as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Eritrea and Mali?
- 1.1%, with Mali ahead.
- How many years of comparable data are there for Eritrea and Mali?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Mali rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Eritrea ranks 147th and Mali ranks 144th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.